Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
about
Plasmablastic Lymphoma: A Review of Current Knowledge and Future DirectionsPlasmablastic lymphoma following combination treatment with fludarabine and rituximab for nongastric mucosa-associated lymphoid tissue lymphoma: a case report and review of literatureLoss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options.Current knowledge on HIV-associated Plasmablastic Lymphoma.VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell typeMolecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component.The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsHuman immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases.Aggressive B-cell lymphomas: how many categories do we need?Spontaneous Post-Transplant Disorders in NOD.Cg- Prkdcscid Il2rgtm1Sug/JicTac (NOG) Mice Engrafted with Patient-Derived Metastatic Melanomas.Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphomaLack and/or aberrant localization of major histocompatibility class II (MHCII) protein in plasmablastic lymphomaOrbital plasmablastic lymphoma: a clinico-pathological correlation of a rare disease and review of literatureLong-term survivor of human immunodeficiency virus-associated plasmablastic lymphoma.Human immunodeficiency virus-negative plasmablastic lymphoma: A case report and literature review.Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component.Plasmablastic lymphoma and related disorders.Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge.Plasmablastic lymphoma of the retroperitoneum in an HIV- and HCV-positive patient: hard to diagnose and harder to treat.Extracavitary primary effusion lymphoma presenting as a cutaneous tumor: a case report and literature review.CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases.Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma.Determining protein biomarkers for DLBCL using FFPE tissues from HIV negative and HIV positive patients.Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1.Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma.Nonsecretory multiple myeloma presenting as an intestinal tumor.An unusual case of Epstein-Barr virus-positive large B-cell lymphoma lacking various B-cell markersDe Novo Unclassifiable CD20-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic and Therapeutic Challenge.Plasmablastic lymphoma in the ano-rectal junction presenting in an immunocompetent man: a case reportMarginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment.Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs.[B-cell neoplasms with plasmacellular and plasmablastic differentiation].BCL7A protein expression in normal and malignant lymphoid tissues.KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas.Expression of a truncated B lymphocyte-induced maturation protein-1 isoform is associated with an incomplete plasmacytic differentiation program in chronic lymphocytic leukemia.Aggressive B-cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings.
P2860
Q26781831-12B05340-2CCA-46D6-AFA0-732AB1220AD5Q26861901-B1FA5B8B-A81F-4281-9032-1B5E555A6475Q27853399-B9BBECEA-30FC-4505-B77C-0BF274A52A24Q34314178-ACF0BE12-2FDC-46A9-A975-0EDCA44AA53AQ34460823-B7999566-C49C-403C-91B1-9BCA0E9B93D8Q34531971-A682D6D7-944F-4004-BADF-96EBA4E940A8Q34534640-846CFC2A-9296-4E73-A50A-5242B79CFA37Q34813064-3EA8FA71-B403-4FD5-A778-E5183D4F9FD2Q35029409-1B141471-4721-403D-824F-A495E769D7E7Q35172532-E3693F2B-C0BB-4888-B3CE-FF8D31CD114DQ35527893-C1E985CB-D377-487F-8CC9-D1E47F238DD7Q35634016-77C8A019-1C8D-4845-9DEC-7B5E5AF2AF12Q35755896-F1B0F3C2-63D1-4A14-8A95-72B74A8E16ECQ35776228-0AD947AA-D60C-40F8-9CD5-25381119AC13Q35776418-E3C34BEA-32B5-4B93-B68D-B83168EAEF1CQ36366994-16FE5825-4967-4ABC-A7AF-9AAB05E9D6C9Q36479575-690F64ED-763A-4948-B0CD-134AF70670FEQ37150933-81AA5E20-4D3C-484A-9049-E4A6CA26CBB6Q37656396-B3AF60A9-1A37-44BE-B713-C901A1DC7652Q37685724-7E0097F7-D13D-4FD3-B621-14D8F41E7971Q37901233-271AC54A-E3D6-4731-A91E-1150C3E2D7F3Q37910910-7B521D26-4188-4830-A3B1-5A2A58A35664Q38007862-BB87A5AA-A9BE-4143-9625-87BA649C6427Q38219363-4D3216FE-7827-4EEB-A498-7EBF91F79465Q38605346-FC8C7FAC-93F5-44DB-9E7A-4E8AC7C69F36Q39136897-1A2F3082-5C5E-4F1E-8596-28177E782D16Q39329062-6AB651CC-437C-4448-8604-BF43D4EAB04FQ39337417-3B2863A9-C49C-4A0B-B9C7-95C5D0570C0DQ39778226-B764539D-9CDD-499B-A013-40E483432415Q40119005-FAA7F0F8-A3A6-423D-AD36-65ED2A77BD28Q40351402-42B93F72-3CCD-44AD-8ADA-5AF71928EEBAQ41923473-29B04436-E4D5-4710-AC60-5C09D24F2C84Q42049729-84F3CC56-E5F6-466E-A72A-C77276BE0CFAQ42287412-6C3369EA-1421-4D1B-AA1B-A37378039D41Q45012890-95319429-B53A-456B-A457-3D24BA5A3654Q45298830-7831346D-4F28-4514-A08F-C194FE0ECCC0Q45830245-1E703EB2-E73F-4C93-B886-3BFFAC78E815Q47400338-69083894-CD51-4CAA-8C10-FE5BB3C770E6Q48337473-F18F63D1-8F3D-45E5-A2F5-434840EA81E2Q48338600-ED177C8D-9D43-4FEE-91D2-575149DED1C4
P2860
Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Aggressive large B-cell lympho ...... artial plasmablastic phenotype
@ast
Aggressive large B-cell lympho ...... artial plasmablastic phenotype
@en
Aggressive large B-cell lympho ...... artial plasmablastic phenotype
@nl
type
label
Aggressive large B-cell lympho ...... artial plasmablastic phenotype
@ast
Aggressive large B-cell lympho ...... artial plasmablastic phenotype
@en
Aggressive large B-cell lympho ...... artial plasmablastic phenotype
@nl
prefLabel
Aggressive large B-cell lympho ...... artial plasmablastic phenotype
@ast
Aggressive large B-cell lympho ...... artial plasmablastic phenotype
@en
Aggressive large B-cell lympho ...... artial plasmablastic phenotype
@nl
P2093
P2860
P50
P1433
P1476
Aggressive large B-cell lympho ...... artial plasmablastic phenotype
@en
P2093
Ana-Rosa Gonzalez-Medina
Carlos Montalbán
Eulogio Conde
Javier Menarguez
Juan F García
Lorena Maestre
Lydia Sanchez-Verde
M Carmen Ruiz-Marcellan
Manuela Mollejo
Socorro-María Rodriguez-Pinilla
P2860
P304
P356
10.3324/HAEMATOL.2009.016113
P577
2010-04-23T00:00:00Z